Innovita Biological Technology Co. Ltd. A (688253) — Cash Flow Quality Index
Innovita Biological Technology Co. Ltd. A (688253) has a Cash Flow Quality Index of 1.34x as of December 2025. Operating cash flow of CN¥193.13 Million exceeds net income of CN¥144.47 Million, indicating high earnings quality where cash backs reported profits. Explore Innovita Biological Technology Co. Ltd. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Innovita Biological Technology Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Innovita Biological Technology Co. Ltd. .
Annual Cash Flow Quality Index for Innovita Biological Technology Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Innovita Biological Technology Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | CN¥193.13 Million | CN¥144.47 Million | ▲ +7.5% |
| 2024 | 1.24x | CN¥305.46 Million | CN¥245.69 Million | ▼ -16.8% |
| 2023 | 1.49x | CN¥259.85 Million | CN¥173.95 Million | ▲ +78.0% |
| 2022 | 0.84x | CN¥126.43 Million | CN¥150.68 Million | ▼ -5.1% |
| 2021 | 0.88x | CN¥106.27 Million | CN¥120.25 Million | ▼ -21.4% |
| 2020 | 1.12x | CN¥639.82 Million | CN¥569.00 Million | — |